SCHEMBL3316630

SCHEMBL3316630

CCOCCC(C)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17920060 1.00
SCHEMBL19457499 1.00
SCHEMBL14642985 0.95 ALDH1A1 (0.36)
SCHEMBL15218457 0.88 ALDH1A1 (0.43)
SCHEMBL7518724 0.88 HSD17B10 (0.36)
SCHEMBL20064605 0.83 HSD17B10 (0.44)
SCHEMBL6173845 0.83 HSD17B10 (0.33)
SCHEMBL20850620 0.81 HSD17B10 (0.42)
SCHEMBL21598304 0.81 ALDH1A1 (0.38)
SCHEMBL21598310 0.81 ALDH1A1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4289824-A1 URACIL COMPOUND CONTAINING CARBOXYLATE FRAGMENT AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION, AND USE Jiangsu Flag Chemical Industry Co., Ltd. (CN) 2023-12-13 EP disclosed
EP-2132167-B1 METHOD FOR THE PRODUCTION OF beta-KETONITRILES BASF SE (DE) 2013-12-25 EP disclosed
US-8501748-B2 Method for the production of β-ketonitriles BASF SE (DE) 2013-08-06 US disclosed
US-20130005970-A1 Method for the production of beta-ketonitriles BASF SE (DE) 2013-01-03 US disclosed
US-8309751-B2 Method for the production of β-ketonitriles BASF SE (DE) 2012-11-13 US disclosed
US-8178543-B2 growth factor receptor tyrosine kinase inhibitor; anticarcinogenic agents; N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-3-hydroxy-3-methylbutanamide TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-05-15 US disclosed
US-20110319380-A1 Compounds for Treating Disorders Mediated by Metabotropic Glutamate Receptor 5, and Methods of Use Thereof SUNOVION PHARMACEUTICALS INC. (US) 2011-12-29 US disclosed
US-20100105903-A1 Method for the production of beta-ketonitriles BASF SE (DE) 2010-04-29 US disclosed
EP-2132167-A1 METHOD FOR THE PRODUCTION OF -KETONITRILES BASF SE (DE) 2009-12-16 EP disclosed
US-20090203717-A1 FUSED HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-08-13 US disclosed
US-20090029973-A1 FUSED HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-29 US disclosed
WO-2008107397-A1 METHOD FOR THE PRODUCTION OF β-KETONITRILES BASF SE (DE) 2008-09-12 WO disclosed